Suppr超能文献

终身疫苗接种成本:西欧概述。

The cost of vaccination throughout life: A western European overview.

作者信息

Ethgen Olivier, Cornier Murielle, Chriv Emilie, Baron-Papillon Florence

机构信息

a Department of Public Health Sciences, Faculty of Medicine , University of Liège, Liège, Belgium, and SERFAN Innovation , Namur , Belgium.

b Sanofi Pasteur MSD , Lyon , France.

出版信息

Hum Vaccin Immunother. 2016 Aug 2;12(8):2029-2037. doi: 10.1080/21645515.2016.1154649. Epub 2016 Apr 6.

Abstract

Despite the interest of policy makers, the actual investment in vaccination is poorly documented. Our study assessed the costs of vaccination throughout life for a fully immunized Western European citizen. National vaccination calendars for England, France, Germany, Italy, Portugal, Spain and Sweden were retrieved. We differentiated men from women and healthy individuals from those suffering from underlying conditions who require specific additional vaccinations. Vaccine costs and administration fees were retrieved from official national source and calculated from the national healthcare perspective. Vaccinating an individual against up to 17 diseases throughout his entire life and in full compliance with national vaccination calendars cost between €328 and €2,352 (vaccines costs only) and between €443 and €3,395 (administration costs included), the lowest range corresponds to a healthy man in Sweden and the highest to a woman with underlying conditions in England. Vaccination costs varied among countries due to heterogeneous national vaccination calendars and organization. In all countries, adults (18-64 y) and elderly (≥65 y) accounted for the lowest vaccines costs compared with infants (0-24 m) and children/adolescents (2-17 y). In comparison, other mass secondary preventive therapies may be at least 3 times more costly. Vaccination requires a relatively low level of investment per individual. Our estimates should be considered to be the maximum potential costs due to our 100% compliance assumption. Increasing coverage rates would bring additional public health benefits for a relatively low incremental cost. A life-course approach of vaccination should also be encouraged because some missed opportunities remain in senior vaccinations.

摘要

尽管政策制定者对此感兴趣,但疫苗接种的实际投资记录不佳。我们的研究评估了一名完全免疫的西欧公民一生的疫苗接种成本。检索了英国、法国、德国、意大利、葡萄牙、西班牙和瑞典的国家疫苗接种计划。我们区分了男性和女性,以及健康个体与患有基础疾病需要额外特定疫苗接种的个体。疫苗成本和管理费从国家官方来源获取,并从国家医疗保健角度进行计算。一名个体一生接种多达17种疾病疫苗并完全符合国家疫苗接种计划的成本在328欧元至2352欧元之间(仅疫苗成本),以及443欧元至3395欧元之间(包括管理费),最低范围对应瑞典的健康男性,最高对应英国患有基础疾病的女性。由于各国疫苗接种计划和组织的差异,疫苗接种成本因国家而异。在所有国家,与婴儿(0 - 24个月)和儿童/青少年(2 - 17岁)相比,成年人(18 - 64岁)和老年人(≥65岁)的疫苗成本最低。相比之下,其他大规模二级预防疗法的成本可能至少高出3倍。疫苗接种对每个个体的投资水平相对较低。由于我们100%合规的假设,我们的估计应被视为最大潜在成本。提高覆盖率将以相对较低的增量成本带来额外的公共卫生效益。还应鼓励采用终生疫苗接种方法,因为老年疫苗接种仍存在一些错失的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b23/4994732/39d56289127e/khvi-12-08-1154649-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验